BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2126144)

  • 1. A double-blind comparison of fluvoxamine, desipramine and placebo in outpatients with depression.
    Roth D; Mattes J; Sheehan KH; Sheehan DV
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(6):929-39. PubMed ID: 2126144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of major affective disorder with fluvoxamine.
    Lapierre YD; Browne M; Horn E; Oyewumi LK; Sarantidis D; Roberts N; Badoe K; Tessier P
    J Clin Psychiatry; 1987 Feb; 48(2):65-8. PubMed ID: 3100510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine.
    Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS
    Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Belgian multicentre study of fluvoxamine in depressive outpatients.
    Brasseur R; Van Moffaert M; Mesotten F; Ansseau M; Uytdenhoef P; Bartholome F
    Acta Psychiatr Belg; 1985; 85(5):636-43. PubMed ID: 3937441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvoxamine and chlorimipramine in endogenous depression.
    De Wilde JE; Doogan DP
    J Affect Disord; 1982 Sep; 4(3):249-59. PubMed ID: 6215443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.
    Itil TM; Shrivastava RK; Mukherjee S; Coleman BS; Michael ST
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):433S-438S. PubMed ID: 6407504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind clinical trial of fluvoxamine and imipramine in patients with primary depression.
    Guy W; Wilson WH; Ban TA; King DL; Manov G; Fjetland OK
    Psychopharmacol Bull; 1984; 20(1):73-8. PubMed ID: 6425916
    [No Abstract]   [Full Text] [Related]  

  • 15. Randomized double-blind study of fluvoxamine and maprotiline in treatment of depression.
    de Jonghe F; Swinkels J; Tuynman-Qua H
    Pharmacopsychiatry; 1991 Jan; 24(1):21-7. PubMed ID: 1901418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of desipramine and fluvoxamine treatment on the prolactin response to tryptophan. Serotonergic function and the mechanism of antidepressant action.
    Price LH; Charney DS; Delgado PL; Anderson GM; Heninger GR
    Arch Gen Psychiatry; 1989 Jul; 46(7):625-31. PubMed ID: 2500111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvoxamine and imipramine: results of a long-term controlled trial.
    Guelfi JD; Dreyfus JF; Pichot P
    Int Clin Psychopharmacol; 1987 Apr; 2(2):103-9. PubMed ID: 3110264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind comparison of fluvoxamine and dothiepin in the treatment of major affective disorder.
    Mullin JM; Pandita-Gunawardena VR; Whitehead AM
    Br J Clin Pract; 1988 Feb; 42(2):51-5. PubMed ID: 3140864
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of desipramine in depressed outpatients. Response according to research diagnosis criteria diagnoses and severity of illness.
    Stewart JW; Quitkin FM; Liebowitz MR; McGrath PJ; Harrison WM; Klein DF
    Arch Gen Psychiatry; 1983 Feb; 40(2):202-7. PubMed ID: 6337580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind comparative study of the clinical efficacy of fluvoxamine and chlorimipramine.
    Dick P; Ferrero E
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):419S-425S. PubMed ID: 6407502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.